United Therapeutics UTHR
NASDAQ UTHR
$588.04 +5.58 (+0.96%)
As of: Nov 10, 2026 · 1:57 PM EST

United Therapeutics (UTHR) Net Long-Term Debt Issued (Repaid) (2014 - 2016)

Updated

United Therapeutics' Net Long-Term Debt Issued (Repaid) was -$8.8 million in FY2016, compared with -$133.2 million in FY2015.

Analysis

United Therapeutics (UTHR) Net Long-Term Debt Issued (Repaid) (2014 - 2016) Analysis & Trends

From FY2010 onward, United Therapeutics has reported Net Long-Term Debt Issued (Repaid) for 7 years.

  • The FY2016 figure marks the highest annual Net Long-Term Debt Issued (Repaid) since FY2013.
  • Per Business Quant data, Net Long-Term Debt Issued (Repaid) in earlier years was -$133.2 million in FY2015, -$177.8 million in FY2014, -$1.32 million in FY2013 and -$999,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -1.00 Mn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 9.98 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 United Therapeutics 25.03 Bn 15.22 Bn 733.40 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2016 -900,000.00
Jun 30, 2016 -7.80 Mn
Mar 31, 2016 -100,000.00
Dec 31, 2015 -26.10 Mn
Sep 30, 2015 -2.80 Mn
Jun 30, 2015 -90.30 Mn
Mar 31, 2015 -14.00 Mn
Dec 31, 2014 -37.80 Mn
API Access

United Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=UTHR&period=max&api_key=YOUR_API_KEY